Finerenone reduces Incidence of Heart Failure in Diabetics with Kidney Disease

被引：0
|
作者：
Franke, Katharina
机构：
来源：
AKTUELLE KARDIOLOGIE | 2022年 / 11卷 / 03期
关键词：
D O I：
10.1055/a-1826-4716
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Der im Februar 2022 in Europa zugelassene selektive nichtsteroidale Mineralokortikoid-Rezeptor-Antagonist Finerenon hat gunstige Auswirkungen auf kardiorenale Endpunkte, wie vor Kurzem in der FIDELIO-DKD und in der FIGARO-DKD-Studie gezeigt werden konnte. Eine praspezifizierte Post-hoc-Analyse der FIGARO-DKD-Studie ergab jetzt insbesondere auch protektive Wirkungen der Substanz im Hinblick auf verschiedene Herzinsuffizienz-Endpunkte.
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [21] Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease
    Anjum, Deewa Zahir
    Bonde, Anders N.
    Fosbol, Emil
    Garred, Caroline Hartwell
    Gislason, Gunnar
    Elmegaard, Mariam
    Knigge, Pauline
    Torp-Pedersen, Christian
    Andersson, Charlotte
    Pfeffer, Marc A.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Petrie, Mark C.
    Kober, Lars
    Schou, Morten
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
  • [22] Impact of Chronic Kidney Disease on Incidence of Atrial Fibrillation Following Heart Failure Exacerbation
    Fretz, Thomas
    Fortna, Sarah
    Tanawuttiwat, Tanyanan
    Ilonze, Onyedika
    Das, Mithilesh
    CIRCULATION, 2024, 150
  • [23] Heart failure in patients with kidney disease
    Tuegel, Courtney
    Bansal, Nisha
    HEART, 2017, 103 (23) : 1848 - 1853
  • [24] Bariatric Surgery Reduces the Incidence of Heart Failure in Patients With Obesity
    Kostanjsek, Luke
    Ardissino, Maddalena
    Moussa, Osama
    Collins, Peter
    Purkayastha, Sanjay
    CIRCULATION, 2021, 144
  • [25] A Novel Heart Failure Disease Management Strategy Reduces Heart Failure Readmissions in Veterans with Heart Failure
    Maska, Edlira
    Jungklaus, Tamarah
    Mullikin, Amy
    Anderson, Shawn
    Reeder, Don
    Chapman, Donald
    Schmalfuss, Carsten
    Aranda, Juan
    Schofield, Richard
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S115 - S115
  • [26] A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Boehm, Michael
    Gheorghiade, Mihai
    Kober, Lars
    Krum, Henry
    Maggioni, Aldo P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Zannad, Faiez
    Kim, So-Young
    Nowack, Christina
    Palombo, Giovanni
    Kolkhof, Peter
    Kimmeskamp-Kirschbaum, Nina
    Pieper, Alexander
    Pitt, Bertram
    EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2105 - 2114
  • [27] A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease
    Sato, Naoki
    Ajioka, Masayoshi
    Yamada, Takahisa
    Kato, Masaharu
    Myoishi, Masafumi
    Yamada, Takashi
    Kim, So-Young
    Nowack, Christina
    Kolkhof, Peter
    Shiga, Tsuyoshi
    CIRCULATION JOURNAL, 2016, 80 (05) : 1113 - +
  • [28] Time to Significant Benefit of Finerenone in Patients With Heart Failure
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Lam, Carolyn S. P.
    Senni, Michele
    Shah, Sanjiv J.
    Voors, Adriaan A.
    Zannad, Faiez
    Pitt, Bertram
    Mcmurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (02) : 199 - 202
  • [29] Diastolic heart failure in diabetics
    Ramaraj, Radhakrishnan
    CARDIOLOGY, 2008, 111 (04) : 268 - 268
  • [30] Fine-heart: an integrated pooled analysis of finerenone across 3 phase iii trials of heart failure and chronic kidney disease and type 2 diabetes
    Vaduganathan, M.
    Jhund, P.
    McMurray, J. J.
    Solomon, S. D.
    DIABETOLOGIA, 2024, 67 : S511 - S512
12345